Axsome Therapeutics, Inc. · NASDAQ:AXSM
Maizel Ari sold 7,500 Axsome Therapeutics, Inc. shares (Form 4)
Traded Apr 22, 2026 · Filed Apr 23, 2026
On Apr 22, 2026, Maizel Ari (Chief Commercial Officer) sold 7,500 Axsome Therapeutics, Inc. shares at US$182.42 for US$1.37M under a trading plan, leaving 0 shares. Filed Apr 23, 2026 (Form 4).
- Sold
- 7,500 shares
- Price
- US$182.42
- Value
- US$1.37M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 22, 2026 | Common Stock | Option exercise | 7,500 | US$70.73 | 7,500 | Direct |
| Apr 22, 2026 | Common Stock | Sale | 7,500 | US$182.42 | 0 | Direct |